Cover Image
市場調查報告書

春季角膜結膜炎:全球臨床實驗趨勢

Vernal Keratoconjunctivitis Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 339389
出版日期 內容資訊 英文 41 Pages
訂單完成後即時交付
價格
Back to Top
春季角膜結膜炎:全球臨床實驗趨勢 Vernal Keratoconjunctivitis Global Clinical Trials Review, H2, 2016
出版日期: 2016年12月21日 內容資訊: 英文 41 Pages
簡介

春季角膜結膜炎是尤其常見於年輕男子的過敏性結膜炎。

本報告提供春季角膜結膜炎臨床實驗相關之最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,實驗對象採用狀況,並彙整有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 春季角膜結膜炎
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:眼科疾病治療藥臨床實驗上春季角膜結膜炎的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:眼科疾病治療藥臨床實驗上春季角膜結膜炎的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

春季角膜結膜炎治療藥臨床實驗上目標的達成情形

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Astellas Pharma Inc.
    • 千壽製藥
    • Santen S.A.S. (Inactive)
    • 參天製藥
    • Novartis AG
    • Novagali Pharma SA
    • Laboratoires Thea S.A.
    • Funds for Research in Ophthalmology
    • Chiltern International Limited
    • Ajanta Pharma Limited
  • 有代表性的研究機關·醫院臨床實驗概要
    • Campus Bio-Medico University Rome
    • Azienda Ospedaliero-Universitaria Meyer
    • Faculty of Medicine Siriraj Hospital, Mahidol University
    • Ghent University Hospital
    • 京都府立醫科大學

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4007CTIDB

GlobalData's clinical trial report, "Vernal Keratoconjunctivitis Global Clinical Trials Review, H2, 2016" provides an overview of Vernal Keratoconjunctivitis clinical trials scenario. This report provides top line data relating to the clinical trials on Vernal Keratoconjunctivitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • Clinical Trials by Region 5
  • Clinical Trials and Average Enrollment by Country 6
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 8
  • Top Five Countries Contributing to Clinical Trials in Europe 9
  • Top Countries Contributing to Clinical Trials in North America 10
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 11
  • Clinical Trials by G7 Countries: Proportion of Vernal Keratoconjunctivitis to Ophthalmology Clinical Trials 12
  • Clinical Trials by Phase in G7 Countries 13
  • Clinical Trials in G7 Countries by Trial Status 14
  • Clinical Trials by E7 Countries: Proportion of Vernal Keratoconjunctivitis to Ophthalmology Clinical Trials 15
  • Clinical Trials by Phase in E7 Countries 16
  • Clinical Trials in E7 Countries by Trial Status 17
  • Clinical Trials by Phase 18
  • Clinical Trials by Trial Status 19
  • Clinical Trials by End Point Status 20
  • Subjects Recruited Over a Period of Time 21
  • Clinical Trials by Sponsor Type 22
  • Prominent Sponsors 23
  • Top Companies Participating in Vernal Keratoconjunctivitis Therapeutics Clinical Trials 24
  • Prominent Drugs 26
  • Clinical Trial Profile Snapshots 27

Appendix 38

  • Abbreviations 38
  • Definitions 38
  • Research Methodology 39
  • Secondary Research 39
  • About GlobalData 40
  • Contact Us 40
  • Disclaimer 40
  • Source 41

List of Tables

List of Tables

  • Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials by Region, 2016* 5
  • Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
  • Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
  • Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 8
  • Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 9
  • Vernal Keratoconjunctivitis Therapeutics Clinical Trials, North America, Top Countries, 2016* 10
  • Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 11
  • Proportion of Vernal Keratoconjunctivitis to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 12
  • Vernal Keratoconjunctivitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
  • Vernal Keratoconjunctivitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
  • Proportion of Vernal Keratoconjunctivitis to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 15
  • Vernal Keratoconjunctivitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 16
  • Vernal Keratoconjunctivitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 17
  • Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials by Phase, 2016* 18
  • Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19
  • Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20
  • Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21
  • Vernal Keratoconjunctivitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 22
  • Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23
  • Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 25
  • Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26

List of Figures

List of Figures

  • Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
  • Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
  • Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
  • Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 8
  • Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 9
  • Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 11
  • Proportion of Vernal Keratoconjunctivitis to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 12
  • Vernal Keratoconjunctivitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
  • Vernal Keratoconjunctivitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
  • Proportion of Vernal Keratoconjunctivitis to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 15
  • Vernal Keratoconjunctivitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 16
  • Vernal Keratoconjunctivitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 17
  • Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 18
  • Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19
  • Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20
  • Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21
  • Vernal Keratoconjunctivitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 22
  • Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23
  • Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24
  • Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26
  • GlobalData Methodology 39
Back to Top